Quebec implements public reimbursement of Pluvicto - a defining milestone for radioligand therapy in Canada

3 July 2025 - Pluvicto now publicly funded in provinces covering most Canadians, offering renewed hope to those facing progressive PSMA ...

Read more →

Bayer's Adempas gets insurance coverage in Korea 11 years after approval

21 May 2025 - The pulmonary arterial hypertension medicine Adempas (riociguat) will be covered by national health insurance starting next ...

Read more →

Top level push for taxpayer funding of weight loss drugs gathers pace

3 July 2025 - Pharma giants are sweating on the results of a federal government request for guidance on adding weight ...

Read more →

Calls for 'missing piece' menopause drug to be added to the PBS

2 July 2025 - A key treatment which could help around one million middle-aged Australian women remains unaffordable to many ...

Read more →

Life-saving breast cancer drug now cheaper thanks to expansion of the PBS

1 July 2025 - A potentially life-saving treatment for early-stage breast cancer will become much more affordable for hundreds of ...

Read more →

New Zealand Pharmaceutical Schedule - 1 July 2025

1 July 2025 - The July 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 July 2025

1 July 2025 - The July 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Xtandi (enzalutamide) now funded in Ontario for all approved prostate cancer indications

26 June 2025 - Today, Astellas Pharma Canada announced that Xtandi (enzalutamide) is now funded by the Ontario Drug Benefit Program ...

Read more →

After 9 year wait, Boehringer’s IPF drug Ofev faces generic threat weeks into Korea launch

24 June 2025 - Just two months after German pharma Boehringer Ingelheim secured long-delayed reimbursement for Ofev in Korea, generics ...

Read more →

Australians with cystic fibrosis benefit from life changing expanded listing

24 June 2025 - More Australians living with cystic fibrosis will have affordable access to a life changing treatment option ...

Read more →

‘Barriers lifted’: cystic fibrosis treatment reaches final waiting patients

23 June 2025 - Ex-Wallabies player Nathan Charles has lived with cystic fibrosis for decades.  ...

Read more →

Cancer inhibitors scrapped from basic insurance for some users

18 June 2025 - National health care institute Zorginstituut Nederland has scrapped several cancer inhibiting drugs from the basic health ...

Read more →

UCB's new psoriasis biologic Bimzelx debuts in Korea with reimbursement

13 June 2025 - Belgium-based UCB's novel psoriasis therapy, Bimzelx (bimekizumab), has officially entered Korea's competitive plaque psoriasis market with ...

Read more →

Gilead’s Trodelvy wins Korean coverage for breast cancer -- too late for some and still off-limits up front

12 June 2025 - It took two years, 100,000 signatures, and a wave of public pressure from patients and doctors. ...

Read more →

Research funding and more treatment options to support the fight against MND

9 June 2025 - The Australian Government is providing a further $4.5 million and listing another treatment to ensure the ...

Read more →